Rhophylac 300
Rhophylac 300 is a medicine authorised by Swissmedic under authorisation number 53609. The authorisation holder is CSL Behring AG. The medicinal product code is Blood products and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 08 March 1996 and the authorisation is valid without a time limit. ATC code J06BB01 places the medicine in the group Immune sera and immunoglobulins.
| Authorisation number | 53609 |
|---|---|
| Name | Rhophylac 300 |
| Full name | Rhophylac 300, Injektionslösung |
| Authorisation holder | CSL Behring AG |
| Medicinal product code | Blood products |
| Dispensing category | B · Prescription only |
| ATC code | J06BB01 |
| First authorisation | 08 March 1996 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Rhophylac 300, Injektionslösung | B | 14 September 2001 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 23 | 1 | Spritze(n) | J06BB01 | 08.09. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Rhophylac 300 authorised in Switzerland?
Yes. Rhophylac 300 is authorised by Swissmedic under authorisation number 53609, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Rhophylac 300 have?
Rhophylac 300 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Rhophylac 300?
The authorisation holder is CSL Behring AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.